Wealthspring Capital LLC Sells 105,653 Shares of M3-Brigade Acquisition V Corp. $MBAV

Wealthspring Capital LLC trimmed its position in shares of M3-Brigade Acquisition V Corp. (NASDAQ:MBAV) by 43.9% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 134,807 shares of the company’s stock after selling 105,653 shares during the quarter. Wealthspring Capital LLC owned about 0.38% of M3-Brigade Acquisition V worth $1,422,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of MBAV. Tuttle Capital Management LLC bought a new position in shares of M3-Brigade Acquisition V during the 2nd quarter worth approximately $437,000. Levin Capital Strategies L.P. purchased a new position in M3-Brigade Acquisition V in the second quarter worth $538,000. MMCAP International Inc. SPC acquired a new position in shares of M3-Brigade Acquisition V during the second quarter worth $16,935,000. Geode Capital Management LLC purchased a new stake in shares of M3-Brigade Acquisition V during the 2nd quarter valued at $1,978,000. Finally, Alberta Investment Management Corp purchased a new stake in shares of M3-Brigade Acquisition V during the 2nd quarter valued at $27,943,000.

M3-Brigade Acquisition V Price Performance

NASDAQ MBAV opened at $10.69 on Wednesday. M3-Brigade Acquisition V Corp. has a 12-month low of $10.06 and a 12-month high of $13.73. The company has a fifty day simple moving average of $10.62 and a two-hundred day simple moving average of $10.82.

Insider Transactions at M3-Brigade Acquisition V

In other news, major shareholder Fitzgerald & Co. Cantor bought 3,529,081 shares of M3-Brigade Acquisition V stock in a transaction that occurred on Wednesday, December 17th. The stock was bought at an average price of $10.80 per share, for a total transaction of $38,114,074.80. Following the purchase, the insider directly owned 7,779,865 shares of the company’s stock, valued at approximately $84,022,542. The trade was a 83.02% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of M3-Brigade Acquisition V in a research note on Monday. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company presently has an average rating of “Sell”.

About M3-Brigade Acquisition V

M3-Brigade Acquisition V is a special purpose acquisition company (SPAC) sponsored by M3 Inc, a global healthcare information and technology provider, and Brigade Capital Management, an investment management firm. The company is structured as a blank?check vehicle listed on the Nasdaq Stock Market under the ticker MBAV, with the objective of identifying and completing a business combination in the healthcare, life sciences or related sectors.

The company benefits from the operational expertise of M3’s digital health platform and real?world data capabilities, combined with Brigade’s deep experience in credit and asset management.